Anders L. Carlson, MD
Senior Research Investigator
About

Affiliations/other offices held: Medical director, International Diabetes Center, and director, HealthPartners diabetes program; assistant professor, University of Minnesota Medical School.

Joined the Institute: 2015

Education and training: MD, University of Minnesota Medical School; fellowship in endocrinology, diabetes and metabolism, University of Vermont; residency in internal medicine, Hennepin County Medical Center, Minneapolis.

Overview/research interests: Dr. Carlson’s research interests include diabetes technology, diabetes care delivery and hyperglycemia in oncology patients. Dr. Carlson has participated in several clinical trials through International Diabetes Center focusing on diabetes technology and new therapeutics. He also has experience using molecular techniques in beta cell research.

Publications

CV

Affiliation
positions
  • Sr. Research Investigator, Diabetes
  • Medical Director, International Diabetes Center, International Diabetes Center 2015 -
  • Publications While At HealthPartners
    selected publications
    Journal Article
  • -cell function over time on glycemic outcomes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE): differential treatment effects of dual therapy
    Diabetes care. 2024
  • Continuous glucose monitoring prediction of gestational diabetes mellitus and perinatal complications
    Diabetes Technology & Therapeutics. 2024
  • Continuous glucose monitoring profiles in pregnancies with and without gestational diabetes mellitus
    Diabetes care. 2024
  • Continuous glucose monitoring-derived differences in pregnancies with and without adverse perinatal outcomes
    Obstetrics and Gynecology. 2024
  • Control-IQ technology use in individuals with high insulin requirements: results from the Multicenter Higher-IQ Trial
    Journal of Diabetes Science and Technology. 2024
  • Expert panel recommendations for a standardized ambulatory glucose profile report for connected insulin pens
    Diabetes Technology & Therapeutics. 2024
  • Glucose levels measured with continuous glucose monitoring in uncomplicated pregnancies
    BMJ open diabetes research & care. 2024
  • Increase access, reduce disparities: recommendations for modifying medicaid CGM coverage eligibility criteria
    Journal of Diabetes Science and Technology. 2024
  • The use of rescue insulin in the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE)
    Diabetes care. 2024
  • Two years with a tubeless automated insulin delivery system: a single-arm multicenter trial in children, adolescents, and adults with Type 1 diabetes
    Diabetes Technology & Therapeutics. 2024
  • Consensus recommendations for the use of automated insulin delivery technologies in clinical practice
    Endocrine Reviews. 2023
  • Improved glycemia with hybrid closed-loop versus continuous subcutaneous insulin infusion therapy: results from a randomized controlled trial
    Diabetes Technology & Therapeutics. 2023
  • Safety and efficacy of the Omnipod 5 Automated Insulin Delivery System in adults with type 2 diabetes: from injections to hybrid closed-loop therapy
    Diabetes care. 2023
  • Safety and glycemic outcomes during the MiniMed(TM) advanced hybrid closed-loop system pivotal trial in children and adolescents with type 1 diabetes
    Diabetes Technology & Therapeutics. 2023
  • Benefit of continuous glucose monitoring in reducing hypoglycemia is sustained through 12 months of use among older adults with type 1 diabetes
    Diabetes Technology & Therapeutics. 2022
  • How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: findings from the first investigation with the Omnipod® 5 System
    Diabetes Research and Clinical Practice. 2022
  • Real-world evidence supporting Tandem Control-IQ Hybrid Closed-Loop success in the Medicare and Medicaid type 1 and type 2 diabetes populations
    Diabetes Technology & Therapeutics. 2022
  • Safety and glycemic outcomes during the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in adolescents and adults with type 1 diabetes
    Diabetes Technology & Therapeutics. 2022
  • Symptomatic diabetic autonomic neuropathy in type 1 diabetes (T1D): findings from the T1D exchange
    Journal of Diabetes and Its Complications. 2022
  • A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial
    Lancet (London, England). 2021
  • Continuous glucose monitoring integration for remote diabetes management: virtual diabetes care with case studies
    Diabetes Technology & Therapeutics. 2021
  • Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial
    JAMA. 2021
  • Hypoglycemia and glycemic control in older adults with type 1 diabetes: baseline results from the WISDM Study
    Journal of Diabetes Science and Technology. 2021
  • Improved glycemic control in 3,592 adults with type 2 diabetes mellitus initiating a tubeless insulin management system
    Diabetes Research and Clinical Practice. 2021
  • Initiating insulin in the emergency center and urgent care to prevent hospital admission for patients with hyperglycemia: a unique insulin starter kit
    Journal of Diabetes Science and Technology. 2021
  • Lost in translation: a disconnect between the science and Medicare coverage criteria for continuous subcutaneous insulin infusion
    Diabetes Technology & Therapeutics. 2021
  • Making sense of glucose metrics in diabetes: linkage between postprandial glucose (PPG), time in range (TIR) & hemoglobin A1c (A1C)
    Postgraduate Medicine. 2021
  • Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes
    Diabetes care. 2021
  • Renal complications and duration of diabetes: an international comparison in persons with type 1 diabetes
    Diabetes Therapy. 2021
  • The effect of discontinuing continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin
    Diabetes care. 2021
  • Trial of a new diabetes education model: closing the gap in health disparity for people with diabetes
    Journal of Diabetes Science and Technology. 2021
  • Ultrarapid lispro demonstrates similar time in target range to lispro with a hybrid closed-loop system
    Diabetes Technology & Therapeutics. 2021
  • Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial
    JAMA. 2020
  • International Diabetes Center: COVID-19 won't stop us from fulfilling our mission
    Journal of Diabetes Science and Technology. 2020
  • Evaluation of insulin glargine and exenatide alone and in combination: a randomized clinical trial with continuous glucose monitoring and ambulatory glucose profile analysis
    Endocrine Practice. 2019
  • Impact of diabetes and hyperglycemia on health care utilization, infection risk, and survival in patients with cancer receiving glucocorticoids with chemotherapy
    Journal of Diabetes and Its Complications. 2019
  • The relationships between time in range, hyperglycemia metrics, and HbA1c
    Journal of Diabetes Science and Technology. 2019
  • Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes: efficacy and safety from a randomized double-blind trial
    Diabetes, Obesity & Metabolism. 2018
  • The hybrid closed loop therapy system: a step closer to an artificial pancreas
    Minn Physician. 2017
  • Bilateral adrenal incidentalomas: a case report and review of diagnostic challenges
    Case reports in endocrinology. 2013
  • Review
  • Primary care and diabetes technologies and treatments [review]
    Diabetes Technology & Therapeutics. 2024
  • Primary care and diabetes technologies and treatments [review]
    Diabetes Technology & Therapeutics. 2023
  • Flash glucose monitoring in type 2 diabetes managed with basal insulin in the USA: a retrospective real-world chart review study and meta-analysis [meta-analysis]
    BMJ open diabetes research & care. 2022
  • Primary care and diabetes technologies and treatments [review]
    Diabetes Technology & Therapeutics. 2022
  • Primary care and diabetes technologies and treatments [review]
    Diabetes Technology & Therapeutics. 2021
  • What's wrong with this picture? A critical review of current Centers for Medicare & Medicaid Services coverage criteria for continuous glucose monitoring [review]
    Diabetes Technology & Therapeutics. 2021
  • HbA1c: the glucose management indicator, time in range, and standardization of continuous glucose monitoring reports in clinical practice [review]
    Endocrinology and Metabolism Clinics of North America. 2020
  • Advanced technology in the management of diabetes: which comes first-continuous glucose monitor or insulin pump [review]?
    Current Diabetes Reports. 2019
  • Utilizing the ambulatory glucose profile to standardize and implement continuous glucose monitoring in clinical practice [review]
    Diabetes Technology & Therapeutics. 2019
  • Clinical use of continuous glucose monitoring in adults with type 2 diabetes [review]
    Diabetes Technology & Therapeutics. 2017
  • Audio Document
    Contact
    full name
  • Anders L. Carlson, MD
  • Quick Info
     
    Collaboration
    More Info